missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human OCIAD1 (aa 3-42) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (75%), Rat (75%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60833 (PA5-60833. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Maintains stem cell potency. Increases STAT3 phosphorylation and controls ERK phosphorylation. May act as a scaffold, increasing STAT3 recruitment onto endosomes. Involved in integrin-mediated cancer cell adhesion and colony formation in ovarian cancer (PubMed:20515946). [UniProt]
Specifications
Specifications
| Accession Number | Q9NX40 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 54940 |
| Name | Human OCIAD1 (aa 3-42) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 6030432N09Rik; AI481327; ASRIJ; AW557942; B230209J16Rik; BB021357; Emi2; expressed during mesenchymal induction 2; FLJ20455; Imi2; induced during mesenchymal induction 2; LOC100723738; MGC111072; OCIA; OCIA domain containing 1; OCIA domain-containing protein 1; Ociad1; OCIAD1 protein; Ovarian cancer immunoreactive antigen domain containing 1; Ovarian carcinoma immunoreactive antigen; TPA018 |
| Common Name | OCIAD1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction